Navigation Links
Bacterin International Signs Its Second National GPO Contract for Bacterin Biologics and Its First For Wound Drains with ROi
Date:6/13/2011

BELGRADE, Mont., June 13, 2011 /PRNewswire/ -- Bacterin International Holdings, Inc. ("Bacterin") (NYSE Amex: BONE), a creator and developer of revolutionary bone graft material and anti-microbial coatings for medical applications, today announced a five-year agreement with ROi (Resource Optimization & Innovation), a recognized leader in health care supply chain management, to provide the OsteoSponge® product line, OsteoSelect®DBM Putty, milled and traditional allografts, and the Elutia® Coated Wound Drain to ROi's nationwide network of hospitals and medical practices.  The group purchasing agreement became effective, after performing months of research and evaluation of the Bacterin product lines.

"ROi has developed an industry-wide reputation for innovative, technology-driven, results-oriented approaches to improving supply chain performance, and is a recent recipient of the Nationwide 2010 Search for Supply Chain Excellence Award.  The inclusion of our products in ROi's network is indeed a validation of our technology, as ROi uniquely includes physicians, clinicians, hospital leaders and other purchasing decision-makers' input on product portfolio selection.  As a consequence, a number of surgeons affiliated with several hospitals within the ROi network have supported our entrance into the network and have been eagerly awaiting final approval to begin using our product line," stated Guy Cook, founder and CEO of Bacterin International.

About Bacterin International Holdings, Inc.

BACTERIN INTERNATIONAL HOLDINGS, INC. ("the "Company" or "Bacterin") develops, manufactures and markets biologics products to domestic and international markets.  Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold and promote bone and other tissue growth
'/>"/>

SOURCE Bacterin International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Bacterin International to Present at Noble Financial Capital Markets Seventh Annual Equity Conference on May 16, 2011
2. Bacterin International Secures $1.9 million in Private Placement
3. Bacterin International Updates Fourth Quarter and Full Year 2010 Financial Results
4. Bacterin International Signs LOI to Acquire Assets of Robinson MedSurg LLC
5. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
6. Bacterin International Reconstitutes Its Board of Directors and Appoints Experienced Legal and Financial Professionals
7. Bacterin International Appoints Three New Members to Its Board of Directors
8. Hospital for Special Surgery to Host International Arthritis Summit: Frontiers in Osteoarthritis Research, Prevention and Care
9. Infrared Systems Internationals Subsidiary, AquaLiv Inc., Explains Its Revolutionary Technology in Laymans Terms
10. Unprecedented international meeting releases preliminary vision for our energy future
11. High voltage! Power experts pull out all the stops at international energy meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... A major challenge before new biotechnology start-up ... of Boston-Cambridge, is gaining visibility that can lead to ... Director of Boston’s Adult Stem Cell Technology Center, LLC ... of his company an important priority since he started ... a social media marketing campaign launched earlier ...
(Date:8/28/2014)... “This kit has an improved extraction efficiency and provides ... ppb,” said Mark Tess, PhD, Mycotoxin Product Manager for Charm ... and USDA-GIPSA inspection agencies that have a need to detect ... in a matter of minutes with nothing but our equipment ... and grain before accepting it, but they no longer have ...
(Date:8/28/2014)... , Aug. 28, 2014  Next month, executives from clinical ... key industry events beginning with Patient-Centered Clinical Trials 2014 ... Boston , September 4-5. Patient recruitment experts ... Aaron Fleishman will share insights on the benefits ... variety of tactics – from media to mobile apps – ...
(Date:8/28/2014)... USA (PRWEB) August 27, 2014 Scientists, ... month for SPIE Laser Damage 2014 symposium. ... materials for high-power lasers will run 14-17 September. The ... for optics and photonics . , The premier conference ... understanding laser damage to optical materials will engage researchers ...
Breaking Biology Technology:The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4BBK Worldwide Leads Sessions at Key September Events 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3
... Mass., Jan. 6, 2011 GENFIT (Alternext: ALGFT; ISIN: ... discovery and development, focusing on the early diagnosis and ... its presence at two U.S. events: the 28th J.P. ... and the Biotech Showcase (from January 10th to 12th, ...
... 2011 Verenium Corporation (Nasdaq: VRNM ), ... industrial enzyme solutions, today announced that the ... has been dismissed.  Verenium,s motion for summary judgment to ... District Court for the Southern District of New York. ...
... CARLSBAD, Calif., Jan. 6, 2011 Isis Pharmaceuticals, Inc. ... has added two new drugs to its development pipeline, ... to treat obesity by increasing metabolism, particularly by increasing ... of fibroblast growth factor receptor 4 (FGFR4) in the ...
Cached Biology Technology:GENFIT: Strong U.S. Exposure for Its Biomarker Activity 2GENFIT: Strong U.S. Exposure for Its Biomarker Activity 3Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit 2Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit 3Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline 2Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline 3Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline 4
(Date:8/28/2014)... a significant health risk to people with asthma according to ... and Clinical Immunology . , By critically reviewing the findings ... found that the presence of several types of mould can ... increasing the likelihood of developing the condition. , The research ... Exeter Medical School and is the first time all of ...
(Date:8/28/2014)... Munich have assigned a number of 435-million-year-old fossils ... animals lived in shallow marine habitats and were ... Jurassic strata. , Before they sank to ... were fossilized some 435 million years ago, these ... seas although they were not exactly inconspicuous, ...
(Date:8/27/2014)... North America,s megafauna mastodons, short-faced bears, giant ground ... disappeared close to 13,000 years ago at the end ... extinction has long been debated by scientists who, until ... group of scientists, including UC Santa Barbara,s James Kennett, ... that a comet collision with Earth played a major ...
Breaking Biology News(10 mins):Indoor mold poses health risk to asthma sufferers 2Paleontology: Oldest representative of a weird arthropod group 2Nanodiamonds are forever 2Nanodiamonds are forever 3
... away at the problem of antibiotic resistance now have ... target in bacteria evolves to become resistant to some ... new experimental antibiotics that are being engineered to circumvent ... Led by Thomas A. Steitz, a Howard Hughes Medical ...
... as disturbance makes a landscape susceptible to invasion by ... globe could be contributing to the accelerating spread of ... the June 2005 issue of BioScience. John A. Havel ... and M. Jake Vander Zanden of the University of ...
... ever covered a flashlight with your hand and seen the ... light in the therapeutic window ?that magic wavelength that is ... they can use light at that wavelength to signal manmade ... , Such possibilities will be discussed in a poster and ...
Cached Biology News:Researchers make gains in understanding antibiotic resistance 2Researchers make gains in understanding antibiotic resistance 3Reservoirs may accelerate the spread of invasive aquatic species, researchers say 2Medical molecules designed to respond to visible light that can penetrate tissue 2
Mouse monoclonal [2A4] to Cytokeratin 8 + 18 + 19 ( Abpromise for all tested applications). Antigen: Cytokeratins isolated from cultured pig kidney epithelial cells. Entrez GeneID: 3856 S...
Tube-O-DIALYZER Floats, small....
Nestin, Human...
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392...
Biology Products: